In-vitro Fertilization Market - Top Companies and Manufacturers

Companies Dominating the In-vitro Fertilization (IVF) Landscape

Key companies are focusing on technological advancements such as genetic testing and embryo selection, to enhance success rates. Additionally, many companies are forming strategic partnerships with fertility clinics and research institutes to enhance their service offering and broaden their geographic reach. Other strategies include product launches, mergers, and acquisitions, in addition to investments in automation, and AI-driven technologies. In 2024, CooperSurgical announced the acquisition of ZyMot Fertility, a subsidiary of DxNow, Inc. The acquisition is aimed at adding ZyMot’s first-of-its-kind sperm separation device to CooperSurgical’s portfolio of assisted reproductive technology products and services. Streamlining processes, improving outcomes, reduction in costs, and catering to the growing demand for accessible and efficient IVF treatments are propelling the market players further.

Cook Medical
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Esco Medical
FUJIFILM Irvine Scientific, Inc.
GE HealthCare Technologies, Inc.
Genea BIOMEDX
Gynemed GmBH & Co. KG
Hamilton Thorne Ltd.
IVFtech ApS
Merck KGaA
Nidacon International AB
The Baker Company Inc.
The Cooper Companies Inc.
Thermo Fisher Scientific Inc.
Vitrolife Group

Browse Key Market Insights with Data Illustration:

In-vitro Fertilization Market Size & Share | Growth Forecasts 2037

In the News

In October 2023, Hamilton Throne announced the acquisition of Gynetics Medical Products, N.V., and Gynetics Services B.V. The acquisition is aimed at expanding Gynetics product offerings into additional international markets and increasing direct sales through existing Hamilton Thorne sales channels.
In May 2023, AIVF partnered with Genea Biomedx to launch their integrated system by combining Genea Biomedx's leading Geri time-lapse incubator with AIVF's advanced EMA AI platform. The integrated system is aimed at providing widespread access to personalized, optimized IVF care.
In January 2021, Philips and Merck KGaA collaboratively launched a multi-year partnership aiming at the inclusion of digital technologies in fertility treatments—combining informatics, mobile ultrasound diagnostics, and more.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the in-vitro fertilization market was over USD 21.6 billion.

The market size for the in-vitro fertilization market is projected to reach USD 42.9 billion by the end of 2037 expanding at a CAGR of 5.9% during the forecast period i.e., between 2025-2037.

The major players in the market are Cook Medical, Esco Medical, FUJIFILM Irvine Scientific, Inc., GE HealthCare Technologies, Inc., and others.

In terms of product segment, the equipment segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 30.5% by the end of 2037 and provide more business opportunities in the future.

In-vitro Fertilization Market - Top Companies and Manufacturers

Companies Dominating the In-vitro Fertilization (IVF) Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the in-vitro fertilization (IVF) market?

What is the outlook for the IVF market?

Who are the major players dominating the in-vitro fertilization market?

Which product segment will capture the significant market share for the in-vitro fertilization market by 2037?

Which region will provide more business opportunities for the growth of the in-vitro fertilization market in the future?